We’re proud to celebrate Dr Aparna Rao, Dr Deborah Meyran and Associate Professor @SafeeraHussainy, who have been awarded the 2026 Lea Medals.
Read more: https://t.co/cCk2z2gwrb
New Peter Mac-led research is changing how we think about breast density.
Not only can it make it harder to interpret mammogram scans, there are signs that dense breasts promote more aggressive #cancer growth.
Read more: https://t.co/PAENxdtK2F
New research at Peter Mac led by A/Prof Annette Lim will investigate which patients are most likely to respond #immunotherapy for head and neck cutaneous squamous cell carcinoma.
This work is funded by the Passe and Williams Foundation.
Read more: https://t.co/k2yyR9MB60
Research led by Peter Mac has found a new way to strengthen cancer-fighting T-cells.
Led by Profs Phil Darcy & @paulbeavis4 (Peter Mac) and A/Prof Jason Waithman (UWA), the study shows boosting the protein Flt3L improves T-cell durability.
Read more: https://t.co/2NHqKGucKj
On 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗗𝗮𝘆 𝗼𝗳 𝗪𝗼𝗺𝗲𝗻 𝗮𝗻𝗱 𝗚𝗶𝗿𝗹𝘀 𝗶𝗻 𝗦𝗰𝗶𝗲𝗻𝗰𝗲, we’re proud to unveil a new exhibition celebrating the women driving life-changing #cancer discoveries - and the real impact their work has on patients’ lives.
#WomenInSTEM#IDWGS
Peter Mac health economist Prof Gang Chen received $1.9M in MRFF funding for a project integrating patient-reported outcomes & preferences into cancer medicine funding decisions.
Focused on breast, melanoma & lung cancer, ALPACA aims to strengthen person-centred health tech.
Haematology registrar @PeterMacCC@eddiecliff has co-authored an important publication reviewing 20 years of RCT for #myeloma. Read more here https://t.co/MsdWiX1FGS
For #BreastCancerAwarenessMonth, @CureCancerAu is highlighting Dr. Luis Lara Gonzalez.
His work, supported by Cure Cancer, is uncovering how HER2-positive breast cancers resist treatment—& driving more precise, personalised therapies.
More: https://t.co/68lO6esBBw
A world-first clinical trial at Peter Mac has found that a simple nasal spray can significantly reduce the risk of COVID-19 in cancer patients. Research published today showed the spray reduced the risk of COVID-19 infection by 40%. Read more here - https://t.co/TmCxhLLpE8
A discovery by researchers at Peter Mac shows that blocking a protein called CDK11 can result in the rapid death of cancer cells - a finding that's described as potentially the 'Achilles' heel of conditions like acute myeloid leukaemia (AML) Read more - https://t.co/OsD9Qvq1Yg
The 'Faces of Discovery' exhibition is showcasing some of the amazing researchers at Peter Mac to help celebrate National Science Week! The posters are on display in our Welcome Hall and on Level 7 at Peter Mac or you can go to our website to learn more - https://t.co/wQY72xU56Q
Join Peter Mac’s Research Student Open Day to meet supervisors, chat with students & explore projects.
📅 27 Aug, 4:30pm
📍 Peter MacCallum Cancer Centre
👉 Register now: https://t.co/rPD2nMUUKk
Peter Mac trial suggests a way to dramatically improve outcomes in patients with high-risk forms of large B-cell lymphoma.
💊 Standard chemo + new drug glofitamab
✅ 98% complete response
🔒 86% progression-free at ~2 years
📈 92% overall survival
MORE: https://t.co/ElAKltLLQv
Peter Mac’s Prof @MAF_Dawson has won the 2025 @ASH_hematology William Dameshek Prize – the first Australian to receive this top honour for his world-leading work in epigenetics.
More: https://t.co/OF6ESOAmbw
Ground-breaking, practice-changing research from Prof Danny Rischin & Prof Sandro Porceddu @PeterMacCC and brilliant team of 🌏investigators. 👏
Excellent results for patients with high-risk SCC of skin, presented at #ASCO25@ASCO
Full results @NEJM ➡️ https://t.co/olCGEA9B6h
A record number of Peter Mac researchers presented at #ASCO25 — with global-impact trials, theranostics leadership, ctDNA breakthroughs & more. 🌍
“Our presence is getting bigger and more impactful each year.” – Prof Jayesh Desai.
Read more: https://t.co/zkVo3kffoU
An experimental therapy involving radioactive Terbium, and designed to seek out and kill prostate cancer cells wherever they are in the body, has shown very positive initial results in a first-in-human clinical trial at Peter Mac.
Read more: https://t.co/RmGKKQJ7IZ